Redx Pharma is pleased to announce the launch of its third subsidiary, Redx Immunology Limited ("Redx Immunology"), which will focus on developing new therapies for disorders of the immune system. It ...
AstraZeneca is picking up a delayed preclinical fibrosis candidate from Redx Pharma in a deal that gives the U.K. biotech a much needed cash boost and ignited its shares. The deal is worth just $17 ...
* REDX PHARMA - HAS BEEN IN RECEIPT OF FURTHER PRIVATE APPROACH FROM YESOD BIO-SCIENCES THAT MAY LEAD TO A POSSIBLE CASH OFF FOR CO * REDX PHARMA PLC - PROPOSED CASH OFFER FOR ENTIRE ISSUED AND TO BE ...
Alderley Park, 13 March 2020 Redx Pharma plc (AIM: REDX), the drug discovery and development company focused on cancer and fibrosis announces it has been in receipt of a further private approach from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback